CD274 and hepatocellular carcinoma: Therefore, the combined treatment of immune checkpoint inhibitors, such as PD-1/PD-L1 inhibitors, with the antioxidant drugs and tivozanib or cystathionine β-synthase was highly recommended for the advanced HCC patients with high prognosis score.